StockIQStockIQ.tech

Molina Healthcare Inc. (MOH) Stock Analysis

--

Free AI-powered analysis and research for Molina Healthcare Inc. stock

Sector: Healthcare

MOH snapshot

Data as of 3 Nov 2026 close. Updated daily.

Last close
208.24 USD (-0.10%)
52-week range
121.06 – 244.89
Position in range
70%
1-year change
+41.6%
Market cap (USD)
$10.8B
RSI (14-day)
55
vs 200-day average
+12.5%
MACD
Below signal line
StockIQ score: 44/100 · Mixed signals

Molina Healthcare Inc. scores 44/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 70% of its 52-week range, up 41.6% over the past year. Latest reported figures show a profit margin of -0.1%, return on equity of -1.1% and revenue growth of -3.5%.

What is driving the score
  • RSI Neutral: +5
  • Strong Uptrend: +9
  • MACD Bearish: -8
  • Unprofitable (-0.1%): -15
  • Negative ROE (-1.1%): -10
  • Strong Long-term Uptrend: +8
  • Strong Momentum (+41.6% over 1 year): +8
  • Low Volume (0.4x): -3

Automated, general information only – not financial advice. Scores can be wrong. How the score works

Full MOH report

Molina Healthcare Inc. (MOH) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze MOH Now β†’

πŸ“° Latest Update

Molina Healthcare (MOH) vs. ELV and UNH: Can Margin Recovery and Acquisitions Unlock Long-Term Upside?

Molina Healthcare (MOH) is being compared to competitors Elevance Health (ELV) and UnitedHealth Group (UNH) regarding its potential for margin recovery and growth through acquisitions. Analysts suggest that successful execution of these strategies could unlock significant long-term upside for MOH. This is important for investors as it highlights the company's ability to enhance profitability and compete effectively in the healthcare sector, impacting future stock performance.

Read full article β†’

History

People also watch

UNH
UnitedHealth Group Inc.
--
ABT
Abbott Laboratories
--
ZTS
Zoetis Inc.
--
MDT
Medtronic plc
--
ELVN
Enliven Therapeutics, Inc.
--